Encompass Health (EHC) Stock Price
Encompass Health Price
Encompass Health (EHC) Stock | ISIN US29261A1007 | WKN A2H9HM. The current Encompass Health stock price is 101.33 USD (2026). Revenue is 6.49 B USD. Net income is 599.78 M USD. The P/E ratio is 17.27. Market capitalization is 10.36 B USD. Encompass Health operates in the Health sector.
Over the last 19 years Encompass Health grew revenue by 6.1% annually, reaching 5.37 B USD. Earnings per share have declined at 2.5% per year over the last 17 years. For Encompass Health, the net margin of 8.4% is broadly stable versus 7.9% a few years ago. At today's price the dividend yield works out to roughly 0.46%. The payout ratio is around 31% of earnings. The dividend has grown at 2.5% per year over the past 11 years.
Encompass Health stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Encompass Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Encompass Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Encompass Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Encompass Health Price |
|---|
Encompass Health Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|
| 4.01 | 4.35 | 4.8 | 5.37 | 5.99 | 6.49 | 7.02 | 7.57 |
| 12.56 | 8.32 | 10.42 | 11.91 | 11.54 | 8.33 | 8.12 | 7.78 |
| 95.42 | 95.35 | 95.44 | 95.55 | 85.67 | 79.08 | 73.14 | 67.87 |
| 3.83 | 4.15 | 4.58 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 |
| 410 | 269 | 349 | 452 | 547 | 599 | 651 | 718 |
| 44.88 | -34.39 | 29.74 | 29.51 | 21.02 | 9.51 | 8.68 | 10.29 |
| 1.12 | 0.86 | 0.6 | 0.47 | 0.7 | 0.19 | 2.01 | - |
| – | -23.21 | -30.23 | -21.67 | 48.94 | -72.86 | 957.89 | – |
| 100.2 | 100.4 | 101.3 | 102.2 | 102.2 | 102.2 | 102.2 | 102.2 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Encompass Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Encompass Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Encompass Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Encompass Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Encompass Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Encompass Health stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health business model & stock analysis
Encompass Health SWOT Analysis
Strengths
1. Strong market presence: Encompass Health Corp has a solid position in the healthcare industry, offering a wide range of services in various geographical locations.
2. Established brand reputation: The company is known for its high-quality healthcare services and is trusted by patients and medical professionals alike.
3. Diverse service portfolio: Encompass Health Corp offers comprehensive services including rehabilitation, home health, and hospice care, allowing them to cater to different healthcare needs.
Weaknesses
1. Dependency on government regulations: Changes in healthcare policies and reimbursement guidelines put Encompass Health Corp at risk, as they heavily rely on government funding.
2. Limited international presence: The company operates primarily within the United States, which may limit potential growth opportunities in international markets.
3. Vulnerability to legal and regulatory challenges: Any legal or regulatory issues faced by the company could significantly impact its operations and financial performance.
Opportunities
1. Aging population and increasing healthcare needs: Encompass Health Corp can leverage the growing demand for healthcare services due to the aging population, by expanding its service offerings and targeting specific healthcare needs.
2. Technological advancements: Implementing innovative technologies and digital solutions can enhance operational efficiency, improve patient care, and attract tech-savvy consumers.
3. Potential for mergers and acquisitions: The company can explore strategic partnerships, mergers, or acquisitions to expand its geographic reach, diversify services, and gain a competitive edge.
Threats
1. Intense competition: Encompass Health Corp faces competition from other healthcare providers, including hospitals, clinics, and specialized service providers, which may limit its market share.
2. Economic downturns and healthcare cost pressures: During economic downturns or when healthcare costs become a burden for consumers, Encompass Health Corp may face challenges in maintaining profitability.
3. Regulatory changes and compliance costs: Frequent changes in regulations and increased compliance costs can negatively impact the company's financial performance and operational efficiency.
Encompass Health Segments
Encompass Health Revenue by Segment (1/2)
Max
Details
Encompass Health Revenue by Segment (2/2)
3 Years
5 Years
Max
Details
Encompass Health Eulerpool Fair Value
Encompass Health historical P/E ratio, EBIT multiple, and P/S ratio
Encompass Health annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Encompass Health shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health Dividend History
14 years of dividend payments
Encompass Health dividend history and estimates
Max
Details
Encompass Health dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health Earnings Estimates
Encompass Health Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/30/2026 | 1.51USD | 1.59 BUSD | 2026 Q1 |
| 4/29/2026 | 1.52USD | 1.59 BUSD | 2026 Q1 |
| 2/5/2026 | 1.31USD | 1.56 BUSD | 2025 Q4 |
| 4/25/2024 | 0.92USD | 1.27 BUSD | 2024 Q1 |
| 2/5/2024 | 0.82USD | 1.25 BUSD | 2023 Q4 |
| 7/31/2023 | 0.78USD | 1.17 BUSD | 2023 Q2 |
| 4/25/2023 | 0.77USD | 1.16 BUSD | 2023 Q1 |
| 1/30/2023 | 0.84USD | 1.14 BUSD | 2022 Q4 |
| 10/26/2022 | 0.64USD | 1.08 BUSD | 2022 Q3 |
| 8/1/2022 | 0.98USD | 1.36 BUSD | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Encompass Health stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Encompass Health shareholder structure
| % | Name |
|---|---|
10.13469% | |
8.30148% | |
4.65248% | |
3.44967% | |
3.03891% | |
2.12891% | |
1.99541% | |
1.78454% | |
1.73537% | |
1.61398% |
Encompass Health Executives and Management Board
Mr. Mark Tarr
(63)President, Chief Executive Officer, Director · since 2004
Mr. Douglas Coltharp
(64)Chief Financial Officer, Executive Vice President
Mr. Patrick Darby
(60)Executive Vice President, General Counsel, Secretary
Dr. Elissa Charbonneau
(65)Chief Medical Officer
Mr. Andrew Price
(58)Chief Accounting Officer · since 2012
Encompass Health Supply Chain
Frequently asked questions about Encompass Health
Encompass Health Corp operates as a leading integrated healthcare services provider. The company's business model primarily focuses on offering post-acute healthcare services and rehabilitation therapies. With a network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies, Encompass Health aims to provide high-quality, personalized care to patients recovering from illnesses, injuries, or surgeries. Through its interdisciplinary approach, advanced technologies, and clinical expertise, Encompass Health Corp strives to improve patients' health outcomes and enhance their overall quality of life.
Encompass Health stock
Encompass Health Peer Group
Encompass Health Ticker
Encompass Health FIGI
All fundamentals and in-depth analysis of Encompass Health
Our stock analysis for Encompass Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Encompass Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.